How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

Infections are a major cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL). These can be exacerbated by anti-leukemic treatments. In addition, the typical patients with CLL already have fragilities and background risk factors that apply to the general population for...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Hemasphere
Glavni autori: Rossi, Davide, Shadman, Mazyar, Condoluci, Adalgisa, Brown, Jennifer R., Byrd, John C., Gaidano, Gianluca, Hallek, Michael, Hillmen, Peter, Mato, Anthony, Montserrat, Emili, Ghia, Paolo
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2020
Teme:
Guideline Article - Expert opinion
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7410019/
https://ncbi.nlm.nih.gov/pubmed/32803132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000432
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items